Propanc Biopharma PPCB
NASDAQ PPCB
$0.32 -0.01 (-1.74%)
At close: Oct 21, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Long-Term Deferred Tax (2017 - 2018)

Updated

Propanc Biopharma (PPCB) recorded Long-Term Deferred Tax of $74,791 in fiscal Q4 2018 (quarter ended Jun 30, 2018), up 21.2% from $61,715 a year earlier.

Analysis

Propanc Biopharma (PPCB) Long-Term Deferred Tax (2017 - 2018) Analysis & Trends

  • Across earlier fiscal years, Long-Term Deferred Tax came in at $61,715 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Propanc Biopharma 362,396.14 -1.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 74,791.00
Jun 30, 2017 61,715.00
API Access

Propanc Biopharma Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=PPCB&period=max&api_key=YOUR_API_KEY